Pil Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
- Paid Up Capital ₹ 1.19 Cr
- Company Age 17 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 21.00 Cr
- Satisfied Charges ₹ 13.64 Cr
- Revenue Growth -15.71%
- Profit Growth -90.81%
- Ebitda -147.73%
- Net Worth 0.23%
- Total Assets -8.58%
About Pil Pharmaceuticals
Pil Pharmaceuticals Limited (PPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 08 June 2007 and has a history of 17 years and eight months. Its registered office is in Faridabad, Haryana, India.
The Corporate was formerly known as Pil Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 1.19 Cr.
The company currently has active open charges totaling ₹21.00 Cr. The company has closed loans amounting to ₹13.64 Cr, as per Ministry of Corporate Affairs (MCA) records.
Navdeep Chawla, Siddharth Chawla, and Amita Chawla serve as directors at the Company.
Company Details
- Location
Faridabad, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24233HR2007PLC072072
- Company No.
072072
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
08 Jun 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Pil Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Siddharth Chawla  | Director | 08-Jun-2007 | Current |
| Navdeep Chawla | Whole-Time Director | 08-Jun-2007 | Current |
| Amita Chawla | Director | 01-Apr-2018 | Current |
Financial Performance of Pil Pharmaceuticals.
Pil Pharmaceuticals Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 15.71% decrease. The company also saw a substantial fall in profitability, with a 90.81% decrease in profit. The company's net worth moved up by a moderate rise of 0.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pil Pharmaceuticals?
In 2023, Pil Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Faridabad Industries AssociationNavdeep Chawla is a mutual person
Indo Autotech Ltd.Siddharth Chawla is a mutual person
Psychotropics India LimitedNavdeep Chawla, Siddharth Chawla and 1 more are mutual person
Psychotropics Marketing And Advertising Private LimitedNavdeep Chawla and Amita Chawla are mutual person
Charges (Loans)
₹21.00 Cr
₹13.64 Cr
Charges Breakdown by Lending Institutions
- Yes Bank Limited : 17.00 Cr
- Hdfc Bank Limited : 4.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Sep 2022 | Yes Bank Limited | ₹12.00 Cr | Open |
| 24 Sep 2022 | Yes Bank Limited | ₹5.00 Cr | Open |
| 26 Feb 2019 | Hdfc Bank Limited | ₹4.00 Cr | Open |
| 27 Oct 2021 | Hdfc Bank Limited | ₹5.00 Cr | Satisfied |
| 30 Nov 2016 | Others | ₹1.04 Cr | Satisfied |
How Many Employees Work at Pil Pharmaceuticals?
Pil Pharmaceuticals has a workforce of 63 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pil Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pil Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
